Literature DB >> 15052466

Myoclonus associated with intraperitoneal imipenem.

Keith K Lau, Rudy J Kink, Deborah P Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052466     DOI: 10.1007/s00467-004-1467-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

1.  Neurotoxicity due to imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.

Authors:  M Rivera; M Crespo; J L Teruel; R Marcén; J Ortuño
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

2.  Neurological complication during imipenem/cilastatin therapy in uraemic patients.

Authors:  M Campise
Journal:  Nephrol Dial Transplant       Date:  1998-07       Impact factor: 5.992

3.  Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.

Authors:  G B Calandra; K R Brown; L C Grad; V I Ahonkhai; C Wang; M A Aziz
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

4.  Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.

Authors:  T P Gibson; J L Demetriades; J A Bland
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

5.  Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.

Authors:  G Calandra; E Lydick; J Carrigan; L Weiss; H Guess
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.